Published in Arch Virol on January 01, 1991
Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J Virol (2009) 1.25
Humoral response in Toscana virus acute neurologic disease investigated by viral-protein-specific immunoassays. Clin Diagn Lab Immunol (1999) 1.25
Granada virus: a natural phlebovirus reassortant of the sandfly fever Naples serocomplex with low seroprevalence in humans. Am J Trop Med Hyg (2010) 1.07
Critical epitopes in the nucleocapsid protein of SFTS virus recognized by a panel of SFTS patients derived human monoclonal antibodies. PLoS One (2012) 1.07
Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS One (2010) 1.05
Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization. MAbs (2010) 1.03
Characterization of the Candiru antigenic complex (Bunyaviridae: Phlebovirus), a highly diverse and reassorting group of viruses affecting humans in tropical America. J Virol (2011) 1.03
A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge. Virology (2009) 1.01
Observations on rift valley fever virus and vaccines in Egypt. Virol J (2011) 1.00
Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs. Virol J (2009) 0.98
An assembly model of rift valley Fever virus. Front Microbiol (2012) 0.97
Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells. PLoS One (2014) 0.94
Performance of various commercial assays for the detection of Toscana virus antibodies. Vector Borne Zoonotic Dis (2011) 0.90
Development and Characterization of Monoclonal Antibodies Directed Against the Nucleoprotein of Heartland Virus. Am J Trop Med Hyg (2015) 0.80
The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS One (2013) 0.80
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. Biomed Res Int (2013) 0.80
Development of a novel, single-cycle replicable rift valley Fever vaccine. PLoS Negl Trop Dis (2014) 0.77
Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates. Virus Res (2015) 0.77
Outbreak of paralytic poliomyelitis in Namibia. Lancet (1994) 2.20
Evaluation of the World Health Organisation antibody-testing strategy for the individual patient diagnosis of HIV infection (strategy III). S Afr Med J (1995) 2.01
Sindbis and West Nile virus infections in the Witwatersrand-Pretoria region. S Afr Med J (1986) 1.11
Environmental temperature on the vector competence of Culex univittatus (Diptera: Culicidae) for West Nile virus. J Med Entomol (1993) 1.11
Impact of the introduction of A/Sydney/5/97 H3N2 influenza virus into South Africa. J Med Virol (1999) 1.07
Studies on Rift Valley fever in some African murids (Rodentia: Muridae). J Hyg (Lond) (1978) 1.04
Demonstration of nuclear immunofluorescence in Rift Valley fever infected cells. J Gen Virol (1977) 1.00
A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part V. Virological and serological observations. S Afr Med J (1985) 1.00
Antigenic analysis of West Nile virus strains using monoclonal antibodies. Arch Virol (1988) 0.94
Low antibody avidity in elderly chickenpox patients. J Med Virol (1992) 0.92
The typing of bluetongue virus. Res Vet Sci (1971) 0.91
A new member of the Palyam serogroup of orbiviruses. Vet Rec (1976) 0.90
Experimental assessment of the vector competence of Culex (Culex) neavei Theobald with West Nile and Sindbis viruses in South Africa. Trans R Soc Trop Med Hyg (1986) 0.88
Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains. Res Virol (1992) 0.88
The synergistic neutralization of Rift Valley fever virus by monoclonal antibodies to the envelope glycoproteins. Arch Virol (1992) 0.87
Comparison of an antibody-capture IgM enzyme-linked immunosorbent assay with IgM-indirect immunofluorescence for the diagnosis of acute Sindbis and West Nile infections. J Virol Methods (1989) 0.87
The effect of neutralizing monoclonal antibodies on early events in Rift Valley fever virus infectivity. Res Virol (1994) 0.85
Viral haemorrhagic fever antibodies in Zimbabwe schoolchildren. Trans R Soc Trop Med Hyg (1982) 0.83
An investigation of flavivirus infections of cattle in Zimbabwe Rhodesia with particular reference to Wesselsbron virus. J Hyg (Lond) (1980) 0.83
Trapping and serum testing of rodents caught prior to the outbreak of plague in Rhodesia. Cent Afr J Med (1976) 0.82
Seroprevalence to polio in personnel at a virology institute. J Infect (2001) 0.82
Exposure to hepatitis B virus among South African health care workers--implications for pre-immunisation screening. S Afr Med J (1991) 0.81
Is antenatal screening for rubella and cytomegalovirus justified? S Afr Med J (1993) 0.81
Outbreak of poliomyelitis in Namibia. Lancet (1994) 0.81
Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa. S Afr Med J (1993) 0.80
Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bull World Health Organ (2002) 0.79
Molecular epidemiology of type 1 polioviruses from Africa. J Gen Virol (1997) 0.79
Isolation of Sindbis virus from bat organs. Cent Afr J Med (1982) 0.79
Dengue fever imported from India. A report of 3 cases. S Afr Med J (1987) 0.78
Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells--effects of passage in cell culture and the human gastrointestinal tract. Vaccine (1998) 0.78
A population-based seroprevalence study in South Africa as a tool in the polio eradication initiative. Am J Trop Med Hyg (1998) 0.77
An investigation of the relationship between infection with Toxoplasma gondii and contact with animals. Cent Afr J Med (1974) 0.76
The effects of the bites of Argas brumpti (Acarina: Argasidae) on humans. Cent Afr J Med (1980) 0.75
A slide-ring preparation for cell culture and virological research. Lab Pract (1966) 0.75
Molecular characterisation of type 1 polioviruses associated with epidemics in South Africa. J Med Virol (1997) 0.75
An 'open-air' method for fowl tracheal organ cultures. Res Vet Sci (1972) 0.75
Benefits and limitations of the Witwatersrand influenza and acute respiratory infections surveillance programme. S Afr Med J (1994) 0.75
The prevalence of antibodies to the hepatitis A virus in Owambo children. Trop Gastroenterol (1994) 0.75
Evaluation of the MUREX*ICE HIV-1.O.2 capture enzyme immunoassay for early identification of HIV-1 seroreverting infants in a developing country. Clin Diagn Virol (1997) 0.75
False negativity by an anti-HIV assay kit (IMx 8B32) and evaluation of its replacement (IMx 8C98). J Med Virol (1998) 0.75
Foot-and-mouth disease typing and serology in Zimbabwe. Trop Anim Health Prod (1982) 0.75
Last virologically confirmed cases of wild-type poliomyelitis in South Africa. S Afr Med J (1995) 0.75
Symptomatic rubella re-infection in early pregnancy and subsequent delivery of an infected but minimally involved infant. A case report. S Afr Med J (1990) 0.75
Infestation of cattle by the brown ear tick, Rhipicephalus appendiculatus, does not affect serological responses to foot-and-mouth disease vaccine. Res Vet Sci (1990) 0.75
Nonspecificity of serological tests for cytomegalovirus. S Afr Med J (1992) 0.75
The role of sexual transmission in the epidemiology of hepatitis C virus in black South Africans. Trans R Soc Trop Med Hyg (1992) 0.75
Mycoplasma capricolum associated with arthritis in sheep. Vet Rec (1977) 0.75
Hepatitis B virus prevalence in two institutions for the mentally handicapped. S Afr Med J (1993) 0.75
The molecular characterization of influenza virus strains isolated in South Africa during 1993 and 1994. Res Virol (1996) 0.75
Should hepatitis A vaccination be routinely given to children? S Afr Med J (1999) 0.75
The current epidemiology of hepatitis A infection in South Africa: implications for vaccination. Trans R Soc Trop Med Hyg (1994) 0.75
A comparison of methods for demonstrating antibodies to the virus of infectious bovine rhinotracheitis/infectious pustular vulvovaginitis. Br Vet J (1976) 0.75